Pilot study of ONCOS-102 and pembrolizumab: remodeling of the tumor micro-environment and clinical outcomes in anti-PD1-resistant advanced melanoma

Pilot study of ONCOS-102 and pembrolizumab: remodeling of the tumor micro-environment and clinical outcomes in anti-PD1-resistant advanced melanoma

Saved in:
Bibliographic Details
Published in:Clinical cancer research Vol. 29; no. 1; pp. 100 - 109
Main Authors: Shoushtari, Alexander, Olszanski, Anthony J., Nyakas, Marta, Hornyak, Thomas J., Wolchok, Jedd D., Levitsky, Victor, Kuryk, Lukasz, Hansen, Thomas B., Jäderberg, Magnus
Format: Journal Article
Language:English
Published: 04-01-2023
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1078-0432
1557-3265
DOI:10.1158/1078-0432.CCR-22-2046